Literature DB >> 32047280

The relationship between pigment epithelial detachment and visual outcome in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Kai Xiong Cheong1, Dilraj Singh Grewal2, Kelvin Yi Chong Teo1,3, Alfred Tau Liang Gan1, Glenn Jay Jaffe2, Gemmy Chui Ming Cheung4,5.   

Abstract

BACKGROUND/
OBJECTIVES: To compare the detailed optical coherence tomography (OCT)-based morphological parameters of pigment epithelial detachment (PED) in eyes presenting with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV), and to assess whether these PED-associated parameters influence 1-year visual outcomes. SUBJECT/
METHODS: We analysed images from a prospective observational study of treatment-naive Asian participants with nAMD or PCV. An independent reading centre graded baseline morphological features of PED on spectral-domain OCT, including greatest height, greatest width, greatest volume, morphology (predominantly dome shaped versus peaked), presence of retinal pigment epithelium (RPE) tear and cholesterol bands. The influence of these baseline features on 12 months best corrected visual acuity (BCVA) was evaluated.
RESULTS: Seventy-eight eyes of 78 participants with PED were studied. In total, 40 (51.3%) participants had nAMD and 38 (48.7%) had PCV. Eyes with PCV, compared with nAMD, had PED of greater height (455.9 µm versus 389.9 µm; P = 0.035) and had higher prevalence of RPE tear (22.9 versus 5.3%; P = 0.041). In the multivariate analysis, only baseline BCVA was significantly associated with month 12 BCVA, but none of the PED-associated OCT parameters at baseline influenced month 12 BCVA.
CONCLUSIONS: Despite the differences in PED height and prevalence of RPE tear between nAMD and PCV, none of these PED morphological factors on OCT at baseline significantly influenced visual outcome at 12 months.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32047280      PMCID: PMC7784948          DOI: 10.1038/s41433-020-0803-6

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  38 in total

1.  Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.

Authors:  Sebastian M Waldstein; Christian Simader; Giovanni Staurenghi; N Victor Chong; Paul Mitchell; Glenn J Jaffe; Chengxing Lu; Todd A Katz; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2016-05-04       Impact factor: 12.079

Review 2.  The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis.

Authors:  Ryo Kawasaki; Miho Yasuda; Su Jeong Song; Shih-Jen Chen; Jost B Jonas; Jie Jin Wang; Paul Mitchell; Tien Y Wong
Journal:  Ophthalmology       Date:  2010-01-27       Impact factor: 12.079

3.  Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.

Authors:  Christian Simader; Markus Ritter; Matthias Bolz; Gabor G Deák; Ulrike Mayr-Sponer; Isabelle Golbaz; Michael Kundi; Ursula M Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2014-03-28       Impact factor: 12.079

Review 4.  Age-related macular degeneration.

Authors:  Laurence S Lim; Paul Mitchell; Johanna M Seddon; Frank G Holz; Tien Y Wong
Journal:  Lancet       Date:  2012-05-05       Impact factor: 79.321

5.  Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD.

Authors:  Sebastian M Waldstein; Jonathan Wright; James Warburton; Philippe Margaron; Christian Simader; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2015-10-17       Impact factor: 12.079

6.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

7.  Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study.

Authors:  David Sarraf; Nikolas J S London; Rahul N Khurana; Pravin U Dugel; Shamika Gune; Lauren Hill; Lisa Tuomi
Journal:  Ophthalmology       Date:  2016-08-23       Impact factor: 12.079

Review 8.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.

Authors:  Wan Ling Wong; Xinyi Su; Xiang Li; Chui Ming G Cheung; Ronald Klein; Ching-Yu Cheng; Tien Yin Wong
Journal:  Lancet Glob Health       Date:  2014-01-03       Impact factor: 26.763

9.  Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.

Authors:  Glenn J Jaffe; Daniel F Martin; Cynthia A Toth; Ebenezer Daniel; Maureen G Maguire; Gui-Shuang Ying; Juan E Grunwald; Jiayan Huang
Journal:  Ophthalmology       Date:  2013-05-01       Impact factor: 12.079

View more
  2 in total

1.  Small dome-shaped pigment epithelium detachment in polypoidal choroidal vasculopathy: an under-recognized sign of polypoidal lesions on optical coherence tomography?

Authors:  Yuwei Wang; Qiyu Bo; Huixun Jia; Mengsha Sun; Yang Yu; Peirong Huang; Jing Wang; Nana Xu; Fenghua Wang; Hong Wang; Xiaodong Sun
Journal:  Eye (Lond)       Date:  2021-04-08       Impact factor: 3.775

Review 2.  OCT Biomarkers in Neovascular Age-Related Macular Degeneration: A Narrative Review.

Authors:  Cristian Metrangolo; Simone Donati; Marco Mazzola; Liviana Fontanel; Walter Messina; Giulia D'alterio; Marisa Rubino; Paolo Radice; Elias Premi; Claudio Azzolini
Journal:  J Ophthalmol       Date:  2021-07-17       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.